Incidence of ventilator-associated pneumonia: Egyptian study

被引:8
|
作者
Elkolaly, Reham M. [1 ]
Bahr, Hoda M. [1 ]
El-Shafey, Basem, I [1 ]
Basuoni, Ahmed S. [2 ]
Elber, Eman H. [3 ]
机构
[1] Tanta Univ, Fac Med, Chest Dept, Tanta, Egypt
[2] Tanta Univ, Fac Med, Anaesthia Dept, Tanta, Egypt
[3] Tanta Univ Hosp, Chest Dept, Tanta, Egypt
关键词
hospital acquired pneumonia; intensive care unit; mechanical ventilation; ventilator-associated pneumonia; INTENSIVE-CARE-UNIT; RISK-FACTORS; SUSCEPTIBILITY; ETIOLOGY; ONSET;
D O I
10.4103/ejb.ejb_43_18
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Despite different ICU admission causes, ventilator-associated pneumonia (VAP) is still a common cause of mortality and morbidity in intubated patients and impedes obvious progression in diagnostic modalities and management of these infections. Aim of study The aim of this study was to estimate VAP incidence in Tanta University Hospitals ICUs. Settings and design This was a crossover observational study. Patients and methods This was a one-year study (April 2015 to March 2016), including patients on invasive ventilation who developed VAP, with evaluation of admission and ventilation causes, isolation of causative organisms, and study of used antibiotics and ventilation modes. Statistical analysis Data were statistically analyzed using the SPSS software for Windows (IBM SPSS Statistics 21.0). Results It is a statistics based study aimed to trace infection incidence in national hospital ICUs. Among 222 admitted patients, only 38.4% fulfilled the criteria of VAP. Admission was because of cardiovascular impairment, cardiac arrest, respiratory failure, or head trauma. The ventilation mode at VAP time was assisted control (75%) and synchronized intermittent mandatory ventilation (25%). The minimum intubation period was 7 days, whereas the maximum period was 37 days. Isolated organisms were Pseudomonas (37.5%), Klebsiella (25%), Staphylococcus (20.8%), and methicillin-resistant Staphylococcus aureus (4.2%). The antibiotics used were amikacin, imipenem, vancomycin, levofloxacin, ceftazidime, and teicoplanin (29, 25, 21, 12.5, 8.3, and 4.2%, respectively). The minimum period of antibiotic used was 5 days, whereas the maximum period was 35 days. The highest incidence of VAP occurred in February, whereas the lowest incidence occurred in July. Conclusion The incidence of VAP is still high and varies according to the intubation cause and period, and the underlying morbidity. More efforts must be made to prevent, diagnose, and manage infection early and properly to reduce patient suffering and to reduce the burden on the serving hospitals.
引用
收藏
页码:258 / 266
页数:9
相关论文
共 50 条
  • [41] Ventilator-associated pneumonia
    Gunasekera, P.
    Gratrix, A.
    BJA EDUCATION, 2016, 16 (06) : 198 - 202
  • [42] Is there a continuum between ventilator-associated tracheobronchitis and ventilator-associated pneumonia?
    Nseir, Saad
    Povoa, Pedro
    Salluh, Jorge
    Rodriguez, Alejandro
    Martin-Loeches, Ignacio
    INTENSIVE CARE MEDICINE, 2016, 42 (07) : 1190 - 1192
  • [43] Is there a continuum between ventilator-associated tracheobronchitis and ventilator-associated pneumonia?
    Saad Nseir
    Pedro Povoa
    Jorge Salluh
    Alejandro Rodriguez
    Ignacio Martin-Loeches
    Intensive Care Medicine, 2016, 42 : 1190 - 1192
  • [44] Prevention of Ventilator-Associated Pneumonia and Ventilator-Associated Conditions Reply
    Damas, Pierre
    CRITICAL CARE MEDICINE, 2015, 43 (11) : E528 - E528
  • [45] VENTILATOR-ASSOCIATED COMPLICATION: INCIDENCE, OUTCOME AND RELATIONSHIP WITH VENTILATOR-ASSOCUTED PNEUMONIA
    Bouadma, L.
    Mourvillier, B.
    Garrouste-Orgeas, M.
    Ruckly, S.
    Clec'h, C.
    Souweine, B.
    Voiriot, G.
    Potton, L.
    Darmon, M.
    Allaouchiche, B.
    Argaud, L.
    Azoulay, E.
    Goldgran-Toledano, D.
    Haouache, H.
    Timsit, J. -F.
    INTENSIVE CARE MEDICINE, 2013, 39 : S466 - S466
  • [46] A Prospective Study of Ventilator-Associated Pneumonia in Children
    Srinivasan, Ramya
    Asselin, Jeanette
    Gildengorin, Ginny
    Wiener-Kronish, J.
    Flori, H. R.
    PEDIATRICS, 2009, 123 (04) : 1108 - 1115
  • [47] Is Zero Ventilator-Associated Pneumonia Achievable? Practical Approaches to Ventilator-Associated Pneumonia Prevention
    Guillamet, Cristina Vazquez
    Kollef, Marin H.
    CLINICS IN CHEST MEDICINE, 2018, 39 (04) : 809 - +
  • [48] The Incidence of Ventilator-Associated Pneumonia in Patients Intubated in the Emergency Department
    Stehman, C. R.
    Klompas, M.
    Kapottos, M.
    Takhar, S. S.
    Frendl, G. M.
    Brown, C. A., III
    Seethala, R. R.
    ANNALS OF EMERGENCY MEDICINE, 2013, 62 (04) : S151 - S152
  • [49] The incidence and risk factors of ventilator-associated pneumonia in a Riyadh hospital
    Memish, ZA
    Cunningham, G
    Oni, GA
    Djazmati, W
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (04): : 271 - 273
  • [50] Incidence of and risk factors for ventilator-associated pneumonia in a community hospital
    Mohammadi, M
    Chakurkar, MS
    Dhar, S
    Gupta, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A556 - A556